Stay updated on Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.

Latest updates to the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page
- Check4 days agoChange DetectedThe study page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and introduces a Last verified metadata label, while existing labels such as Verified, Last known status was:, Intervention / Treatment, and Revision have been removed or renamed. These changes reorganize the page's structure and metadata without modifying the underlying study information or eligibility criteria.SummaryDifference2%

- Check12 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the Study Record, reflecting a minor page update. No substantive study content or eligibility details appear to be changed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page shows Revision: v3.5.4 replacing the previous Revision: v3.5.3. This indicates a minor system update rather than changes to study data on the page.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page footer revision label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor technical/version change without affecting the posted study details.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0; no substantive content changes are evident.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.